---
title: Serum Carnosinase 1 Is Not Associated with Insulin Resistance or Glucose Metabolism
  in a Type 1 Diabetes Cohort
date: '2025-02-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40002779/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250226171103&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Background/Objectives: Preclinical studies suggest that the deleterious
  effect of a high serum carnosinase 1 (CN1) concentration is attributed to its adverse
  effects on insulin sensitivity and glucose metabolism. However, there is little
  evidence for a modulating role of CN1 in glucose metabolism in humans. Methods:
  We measured serum CN1 concentration in an observational type 1 diabetes cohort of
  172 patients in whom glucose variability (MAGE, MODD, SD of individual blood glucose,
  mean, and ...'
disable_comments: true
---
Background/Objectives: Preclinical studies suggest that the deleterious effect of a high serum carnosinase 1 (CN1) concentration is attributed to its adverse effects on insulin sensitivity and glucose metabolism. However, there is little evidence for a modulating role of CN1 in glucose metabolism in humans. Methods: We measured serum CN1 concentration in an observational type 1 diabetes cohort of 172 patients in whom glucose variability (MAGE, MODD, SD of individual blood glucose, mean, and ...